Multi-drug resistance (MDR) in lung cancer refers to the phenomenon that the cross-resistance to a variety of unused chemotherapy drugs was caused by a single chemotherapy drug, the related proteins of which mainly included MDR1, MRPs, P-gp, and LRP [30–32]. The gene discussed is MRPS7; the disease is lung carcinoma.